-
Embryology of the Thyroid gland
- Originate from the primitive pharynx and neural cres
- Forms from endodermal diverticulum of the floor of the primitive pharynx
- Follicular elements of thyroid tissue develop during 2nd to 3rd week of fetal life
- Proximal portion forms the foramen caecum
- Distal/caudal segment descents into the neck
- Thyroglossal duct tract is formed during this descent
-
The ultimobranchial bodies are formed from
- tissue from the neural crest and fused fourth and fifth branchial pouches
- gives rise to parafollicular cells (c cells)
- ultimobranchial body fuses with the thyroid gland
- results in parafollicular cells being restricted to a zone within the middle to upper thirds of the thyroid gland
- MTCs commonly arise from this region
-
Inferior parathyroid glands arise from
4th branchial pounches
-
Pyramidal lobe of the thyroid gland arises from
Caudal tract remnant of the thyroglossal duct
-
Ectopic Thyroid tissue arises from
Failure of migration or excessive descent
-
Lingual thyroid arises from
Complete arrest of the descent of the developing thyroid with resulting presence of thyroid tissue at the tongue base
-
Lateral thyroid tissue arises from
- Debate whether lateral neck thyroid tissue represents normal thyroid tissue versus metastatic thyroid carcinoma
- treated as thyroid cancer with resection
-
Features of Thyroglossal duct cyst
- Most common congenital cervical anomaly
- Cyst can be lined by stratified squamous or columnar epithelium
- Can occur anywhere from the base of the tongue to the upper mediastinum
-
Benign Thyroid Lesions
- Thyroiditis
- e.g. Hashimoto Thyroiditis and Riedel Thyroiditis
- Adenomas
- Goiters
-
Types of Thyroiditis
- Chronic lymphocytic Thyroiditis (Hashimoto Thyroiditis)
- - antibodies to thyroid peroxidase and thyroglobulin
-
Riedel Thyroiditis
- rare disorder characterized by fibrosis of the thyroid gland
-
Clinical Features of Hashimoto Thyroiditis
immunologically mediated thyroid cell dmamage by autoantibodies against thyroid peroxidase and thyroglobulin and TSH receptor
-
presents as an incidental asymptomatic goiter in middle-aged women
- can occur at any age
- most common cause of hypothyroidism
-
Types of Thyroid adenomas
- Follicular adenoma
- Hurthle Cell adenoma
- Hyalinizing trabecular adenoma
- Nodular (adenomatous) goiter
-
Malignant Lesions of the Thyroid include
- Papillary carcinoma
- Follicular carcinoma
- Hurthle-cell Variant
- Medullary thyroid carcinoma
- Anaplastic thyroid carcinoma
-
Gross Features of PTC
- Ill-defined margins
- Firm consistency
- Whitish colour
- Granular cut surface
-
Histologic features of PTC
- Papillae
- Subtle irregularities in the nuclear contours
- Pseudoinclusions with cytoplasmic invaginations
- Psammoma bodies
-
Histologic variants of PTC
- Papillary thyroid microcarcinoma
- Follicular variant
- Encapsulated variant
- Diffuse sclerosing variant
- Oxyphilic cell variant
- Tall-cell variant
- Columnar cell variant
-
Pathologic features of PTC
- Multicentric involvement
- Extrathyroidal extension is common
- (muscle, RLN, and trachea)
- Lymph node involvement in 30%
- <5% have distant metastasis at time of diagnosis
-
Risk factors of PTC
- Previous ionizing radiation (e.g. head and neck irradiation for childhood lymphoma)
- Syndromes involving familial PTC: Cowden syndrome
- Family history
-
What is Cowden syndrome
Multiple hamartomas, breast tumours, and follicular/papillary thyroid tumours
-
Clinical Features of Follicular thyroid carcinoma
- 13% of all thryoid carcinomas
- 10-year survival is 60%
- 10 to 15% present with distant metastasis
- Less nodal metastasis
-
What is the 10-year survival of PTC
96%
-
Gross features of FTC
- solitary tumours
- thick fibrous capsule
- hypercellualr
- Frozen section is often not sufficient for diagnosis
- FNA not helpful
-
Variants of FTC
- Minimally invasive
- Widely invasive
-
Risk factors for FTC
- Radiation exposure
- Chronic goiter secondary to hypothyroidism
-
Hurthle Cell Carcinoma
- Traditionally considered a subtype of FTC
- 15% of FTCs
- Histologically, oncocytes rich in mitochondria or Hurthle cells (large, polygonal, follicular cells containing dense eosinophilic cytoplasm, marked nuclear pleomorphism)
- 2% of thyroid carcinomas
-
Clinical Presentation of FTC
- Presents with thyroid mass or nodule
- 35% of patients develop distance metastasis at some point
-
Features of Anaplastic Carcinoma
- <5% of all thryoid malignancies
- highly agressive
- Invariably fatal
- Mean survival from time of diagnosis is 3to 6 months
- Predominantly occurs in older individuals (peak in 7th decade)
- Sites of metastasis: lung, bone, brain, and intestine
-
Clinical Presentation of Anaplastic Thyroid Carcinoma
- Rapidly expanding neck mass or sudden changein size of preexisting goiter
- May have associated symptoms of dysphagia, hoarseness, dyspnea, cough, pain
- Horner's syndrome
-
Gross and Histologic features of Anaplastic thyroid carcinoma
- large, bulky infiltrative masses
- gray-white
- fibrous with areas of focal necrosis and hemorrage
-
Histologic variants of ATC
- Spindle cell
- Giant cell
- pleomorphic
- Malignant fibrous
- Histiocytic
- Squamoid cell
-
Lymphoma of the Thyroid
- <5% of thyroid malignancies
- Mean age of diagnosis of 60 - 65 yrs
- Most common type: low to intermediate grade NHL from B-cells
- Increased risk with Hashimoto thyroiditis
-
Pitfalls of FNA
- Cannot distinguish between benign microfollicular adenomas and differentiated FTCs
- Cannot differentiate Hurthle cell lesion from Hashimoto thyroiditis
-
Patterns of histologic appearance of follicular adenomas
- trabecular
- follicular
- microfollicular
- solid
-
Thyroid FNA categories (Bethesda)
- Risk of Malignancy
- Benign <1%
- Atypia of US 5 - 10%
- Neoplasm 20 - 30%
- Suspicious for Malignancy 50 - 75%
- Malignant 100%
- Non-diagnostic
-
Epidemiology of Thyroid nodules
- Palpable in 4 - 7% of adults (1% in males, 5% in females, increased with age)
- Increases with age (esp. > 50)
- Found incidentally in 10 - 31% of thyroid ultrasound (5% of these are malignant; upto 15% with high risk factors)
-
Benefits of Thyroid FNA
- High accuracy (90 - 100%)
- False positive of <1%
- False negative rates of 1 - 11%
- Safe, inexpensive, easily performed, minimal patient discomfort
-
Recommended follow-up depending on pathologic FNA findings:
- Benign - periodic U/S
- Atypia of unknown significance - Repeat FNA
- Neoplasm - lobectomy/hemithyroidectomy
- Suspicious for malignancy -
- Malignant - proper staging, definitive surgery +/- RT
- Non-diagnostic - repeat FNA
-
Cystic Thyroid lesions
- Low risk of malignancy if simple cysts (1 - 4%)
- Higher risk if:
- mixed cystic and solid nodules
- cysts > 3 cm
- recurring cysts
-
Extent of Thyroid Surgery Definitions
- Partial = removal of a nodule with a larger margin of normal thyroid tissue
- Subtotal = bilateral removal of >50% of each love
- Lobectomy/hemithyroidectomy = complete removal of one lobe + isthmus
- Near total = total extracapsular removal of one lobe including isthmus with less than 10% of contralateral lobe left behind
-
Skin incision for thyroidectomy
- Standard Kocher's incision
- (Curvilinear incision along natural Langerhan's line, crease)
- 4 - 5 cm incision adequate for most cases
- Carry incision through the the skin and subcutaneous layer through the platysma msucle to the lateral extent of the skin
- Dissect subplatysmal skin flaps away from the strap muscle
-
Identification of the RLN
- identify the inferior thyroid artery
- Zuckerkandle tuberculum
- Laterodorsal to Berry's ligament
- Left RLN runs closer to the tracheoesophageal groov
- RLN may pass posteriorly or sperficially to the inferior thyroid artery
-
What is a non-recurrent laryngeal nerve?
Right side - anomalous right subclavian results in absence of nerve curving back up
-
Indications for FNA based on ultrasound features
- High risk history (history of cancer in first degree relative, XRT, prior hemi with +malignancy, MEN2,_ and nodule > 5mm
- >1 cm solid nodule and hypoechoic
- > 1 cm and hyperechoic
- >1.5 cm mixed cystic-solid without suspicious US features
- >2 cm spongiform nodule
-
High risk US findings of thyroid nodules:
- microcalcifications
- hypoechoic
- increased nodular vascularity
- infiltrative margins
- taller than wide
-
US guidance for FNA is recommended for nodules that are:
- Nonpalpable
- Predominantly cystic
- Located posteriorly in the thyroid lobe
- Repeating a nondiagnostic cytology result
-
Follow-up of nodules that are benign on cytology
- 5% false negative rate (increased with size >4 cm)
- serial US q 6 - 18 months after initial FNA
- If stable (no more than a 50% hange in volume or < 20% increase in at least two nodule dimensions in solid nodules), q3 - 5 years
- Repeat FNA if significant change
-
differentiated thyroid cancer includes
- Papillary
- Follicular + 3% that are Hurthle cell/oxyphil tumours
-
Indications for RAI ablation post thyroidectomy
- T3
- T4
- M1
- RAI in N1 disease is questionable
-
Primary tumour (T) staging in Thyroid cancer:
- T1 = <1 cm intrathyroidal or microscopic multifocal
- OR 1 - 2 cm intrathyroidal
- T2 = >2 to 4 cm, intrathyroidal
- T3 = >4 cm in any dimension limited to the thyroid; minimal extrathyroid extension
- T4a = extending beyond the thyroid capsule to invate subcutaneous soft tissues, larynx, trachea, esophagus, or recurrent laryngeal nerve
- T4b = tumour invates prevertebral fascia or encases carotid artery or mediastinal vessels
-
Regional lymph node staging in Thyroid cancer
- Nx = cannot be assessed
- N0 = no regional lymph node metastasis
- N1 = regional lymph node metastasis
- a) Metastasis to level VI
- b) Unilateral or bilateral cervical or mediastinal lymph nodes
-
Complications of RAI ablation
|
|